LSD Microdosing in Biohacking: What Do Placebo-Controlled Trials Actually Show?

LSD microdosing — taking doses around 1/10 to 1/20 of a typical recreational dose, usually every two to three days, in cycles lasting weeks or months — has become over the past decade one of the most recognizable practices in the biohacking community and Silicon Valley culture. Enthusiasts describe a subtle but noticeable improvement in mood, focus, creativity, and overall "flow" at work, without the perceptible psychedelic effects characteristic of a full dose.

The problem with this narrative is fundamental and worth laying out right at the start: for most of the time microdosing was practiced and discussed, no rigorous, controlled scientific trials existed — the entire "evidence" base consisted of anecdotes, online surveys and self-reports from people who knew they were taking LSD. This matters, because simply knowing one is taking a psychoactive substance, combined with a strong expectation of improvement, is one of the most powerful generators of placebo effect in all of psychopharmacology.

A solution to the fundamental methodological problem — how do you blind a trial of a substance whose effects, even at a microdose, some people can recognize — came from an unusual place: the microdosing movement itself. A team at Imperial College London led by Balázs Szigeti designed a "self-blinding" citizen science study, where participants themselves prepared opaque capsules with their own substance or empty control capsules, arranged them in a random order unknown to them, and for four weeks didn't know which day they were taking an actual microdose versus placebo.

The Szigeti study, while methodologically inventive, had its limitations — it relied on self-report from participants in home settings, without full control over dosing and daily environment. That's why independent confirmation from a fully controlled laboratory trial, conducted by Harriet de Wit's team at the University of Chicago, is equally important.

The study's author, Harriet de Wit, commented on the findings directly: the team did not observe a robust effect under these specific research conditions, while also noting the result doesn't definitively rule out potential benefits in other populations (e.g. people with clinically significant depressive symptoms, unlike the healthy volunteers studied in this particular project) or under other dosing schedules spread over longer periods.

It's precisely this difference — between uncontrolled self-report and a trial with genuine, blinded placebo — that explains why the Szigeti and de Wit findings might have surprised so many people deeply convinced of microdosing's benefits based on their own experience. A subjective sense of improvement after taking a substance known to be active is a real but different phenomenon from a proven pharmacological effect of that substance at such a low dose.

For someone considering LSD microdosing for biohacking purposes — improving mood, focus or creativity — the most honest summary of current knowledge is this: two independent, methodologically different but rigorously controlled trials (Szigeti's self-blinding citizen science study and de Wit's laboratory RCT) found no advantage of microdosing over placebo on most measured outcomes. This doesn't mean no one will ever feel a subjective difference — it means the available evidence doesn't confirm that difference comes from LSD's pharmacological action at such a low dose rather than from expectation and placebo effect.

LSD microdosing is a good example of how easily a strong, reproducible placebo effect can be mistaken for a genuine pharmacological action of a substance, especially when the practicing community is motivated, enthusiastic, and actively shares reports that mutually reinforce expectations. Rigorous, blinded trials — which themselves required an inventive solution to a unique methodological problem — consistently failed to confirm these reports. This doesn't disqualify the entire field of psychedelic research, but it should significantly cool enthusiasm specifically for microdosing as a proven biohacking method.